• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

我们准备好进行个性化癌症风险管理了吗?来自乳腺护理提供者的观点。

Are we ready for personalized cancer risk management? The view from breast-care providers.

作者信息

Komatsu Hiroko, Yagasaki Kaori

机构信息

Faculty of Nursing and Medical Care, Keio University, Tokyo, Japan.

出版信息

Int J Nurs Pract. 2014 Feb;20(1):39-45. doi: 10.1111/ijn.12115. Epub 2013 Jun 14.

DOI:10.1111/ijn.12115
PMID:24580974
Abstract

Personalized medicine, the tailoring of prevention and treatment, is the future of routine clinical practice. This approach has started to appear in genetic testing for predisposition to hereditary breast and ovarian cancer (HBOC). We explored how breast-care providers perceived HBOC risk management, using grounded theory. This study found that the frontline healthcare providers perceived HBOC risk management as still being neglected in breast cancer care. Emerging challenges included treatment priority, hesitancy to deal with sensitive issues, easily missed risks, genetic data not being shared among multidisciplinary professionals, and patients being lost to follow-up. Oncology nurses are ideally placed to facilitate communication and utilization of genetic information among multidisciplinary professionals. Specialized outpatient clinics need to be established to follow up individuals at high risk. There is a need to create a system to meet the future demands of personalized medicine in nursing practice.

摘要

个性化医疗,即预防和治疗的定制化,是常规临床实践的未来发展方向。这种方法已开始出现在遗传性乳腺癌和卵巢癌(HBOC)易感性的基因检测中。我们运用扎根理论探讨了乳腺护理人员对HBOC风险管理的看法。本研究发现,一线医疗服务提供者认为在乳腺癌护理中,HBOC风险管理仍被忽视。新出现的挑战包括治疗优先级、处理敏感问题时的犹豫、易被遗漏的风险、多学科专业人员之间未共享基因数据以及患者失访。肿瘤学护士在促进多学科专业人员之间的基因信息沟通和利用方面具有理想的条件。需要设立专门的门诊诊所来对高危个体进行随访。有必要创建一个系统,以满足护理实践中个性化医疗的未来需求。

相似文献

1
Are we ready for personalized cancer risk management? The view from breast-care providers.我们准备好进行个性化癌症风险管理了吗?来自乳腺护理提供者的观点。
Int J Nurs Pract. 2014 Feb;20(1):39-45. doi: 10.1111/ijn.12115. Epub 2013 Jun 14.
2
Communicating risk of hereditary breast and ovarian cancer with an interactive decision support tool.使用交互式决策支持工具来沟通遗传性乳腺癌和卵巢癌的风险。
Patient Educ Couns. 2013 Aug;92(2):188-96. doi: 10.1016/j.pec.2013.04.008. Epub 2013 May 9.
3
American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.美国临床肿瘤学会政策声明更新:癌症易感性基因检测
J Clin Oncol. 2003 Jun 15;21(12):2397-406. doi: 10.1200/JCO.2003.03.189. Epub 2003 Apr 11.
4
[Current clinical issues and recent trends in hereditary breast and ovarian cancer in Japan-genetic testing for HBOC and risk-reducing surgery].[日本遗传性乳腺癌和卵巢癌的当前临床问题及近期趋势——HBOC的基因检测与降低风险手术]
Gan To Kagaku Ryoho. 2014 Nov;41(11):1333-9.
5
[Present status and tasks for genetic testing and risk-reducing surgery in patients with hereditary breast and ovarian cancer].[遗传性乳腺癌和卵巢癌患者基因检测及降低风险手术的现状与任务]
Gan To Kagaku Ryoho. 2012 Apr;39(4):525-31.
6
Hereditary breast/ovarian cancer syndrome: a primer for obstetricians/gynecologists.遗传性乳腺癌/卵巢癌综合征:妇产科医生指南。
Obstet Gynecol Clin North Am. 2013 Sep;40(3):475-512. doi: 10.1016/j.ogc.2013.05.009. Epub 2013 Jul 30.
7
Hereditary breast-ovarian cancer: clinical findings and medical management.遗传性乳腺癌-卵巢癌:临床发现与医学管理
Plast Surg Nurs. 2007 Jul-Sep;27(3):124-7. doi: 10.1097/01.PSN.0000290280.48197.e7.
8
Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.进行遗传性乳腺癌和卵巢癌基因检测的女性与其未进行检测的高危亲属之间的差异。
Oncol Nurs Forum. 2011 Sep;38(5):572-81. doi: 10.1188/11.ONF.572-581.
9
Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.与BRCA1和BRCA2基因突变相关的遗传性乳腺癌卵巢癌综合征家族中女性接受预防性卵巢切除术后的腹腔内癌转移
Gynecol Oncol. 2005 May;97(2):457-67. doi: 10.1016/j.ygyno.2005.01.039.
10
Nursing implications of personalized and precision medicine.个性化与精准医学的护理启示
Semin Oncol Nurs. 2014 May;30(2):130-6. doi: 10.1016/j.soncn.2014.03.007.

引用本文的文献

1
Exploring healthcare personnel's knowledge, barriers, and innovative approaches in personalised oncology medicine: a scoping review.探索医疗保健人员在个性化肿瘤医学方面的知识、障碍和创新方法:一项范围综述
Crit Public Health. 2025 Jun 28;35(1):2520410. doi: 10.1080/09581596.2025.2520410. eCollection 2025.
2
Cost-effectiveness of bringing a nurse into an Italian genetic day clinic: a before and after study.将护士引入意大利遗传日诊所的成本效益:一项前后对照研究。
BMC Health Serv Res. 2023 Nov 20;23(1):1278. doi: 10.1186/s12913-023-10238-8.
3
Success Factors and Barriers in Combining Personalized Medicine and Patient Centered Care in Breast Cancer. Results from a Systematic Review and Proposal of Conceptual Framework.
乳腺癌个性化医疗与以患者为中心的护理相结合的成功因素与障碍。系统评价结果及概念框架提案
J Pers Med. 2021 Jul 13;11(7):654. doi: 10.3390/jpm11070654.
4
Person Centered Care and Personalized Medicine: Irreconcilable Opposites or Potential Companions?以患者为中心的护理与个性化医疗:不可调和的对立面还是潜在的伙伴?
Health Care Anal. 2019 Mar;27(1):45-59. doi: 10.1007/s10728-017-0347-5.
5
Identifying Needs: a Qualitative Study of women's Experiences Regarding Rapid Genetic Testing for Hereditary Breast and Ovarian Cancer in the DNA BONus Study.识别需求:DNA BONus研究中关于遗传性乳腺癌和卵巢癌快速基因检测的女性经历的定性研究
J Genet Couns. 2017 Feb;26(1):182-189. doi: 10.1007/s10897-016-9996-z. Epub 2016 Jul 28.